Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON34554
NL-OMON34554
Completed
Not Applicable

A multicentre, randomized controlled trial of neurolysis for mild ulnar neuropathy at the elbow - effect of neurolysis for mild ulnar neuropathy at the elbow

Sint Elisabeth Ziekenhuis0 sites120 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsnerve at elbowulnar neuropathy10034606

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
nerve at elbow
Sponsor
Sint Elisabeth Ziekenhuis
Enrollment
120
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Sint Elisabeth Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • •a. Age 18 years or more.
  • •b. Clinical signs of an ulnar neuropathy (i.e., pain, numbness or paraesthesias in the area of the ulnar nerve, weakness or clumsiness of ulnar muscles).
  • •c. Duration of symptoms \< 9 months.
  • •d. MRC sumscore of the flexor carpi ulnaris (FCU), flexor digitorum profundus digiti IV \+ V (FDP IV\-V), abductor digiti minimi (ADM) and first dorsal interosseous I (FDI) muscles \> 16 (of a maximum score of 4 x 5 \= 20\).
  • •e. Electrophysiological \* or sonographic \*\* evidence of localization of the lesion at the elbow.
  • •f. Informed written consent.

Exclusion Criteria

  • •a. evidence of a coexistent polyneuropathy.
  • •b. History of hereditary neuropathy with liability to pressure palsies
  • •c. Traumatic origin of UNE.
  • •d. Malignancy.
  • •e. Previous or current use of chemotherapy.
  • •f. Unable to follow up

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A multicentre, randomized controlled trial of neurolysis for mild ulnar neuropathy at the elbowulnar neuropathy, neurolysis, conservative treatmentulnaropathie, neurolyse, conservatief beleid
NL-OMON27989dr. L.H. VisserSt Elisabeth Hospitalhilvarenbeekseweg 605022 GC Tilburgthe Netherlands013-5392552Fax 013-5422538E-mail l.visser@elisabeth.nldr. R. BeekmanAtrium Medical CentrePo Box 4446 6401 CX Heerlen the Netherlandsr.beekman@atriummc.nl045-5766700drs. A.H.C.M.L. SchreuderAtrium Medical CentrePo Box 4446 6401 CX Heerlen the NetherlandsTSR01@atriummc.nl045-5766700120
Recruiting
Phase 3
Australasian Resuscitation In Sepsis Evaluation Randomised Controlled Trial
ACTRN12608000053325Australian and New Zealand Intensive Care Research Centre1,600
Completed
Not Applicable
The clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockSevere sepsis/septic shockInfections and InfestationsOther septicaemia
ISRCTN36307479Intensive Care National Audit and Research Centre (ICNARC) (UK)1,260
Active, not recruiting
Phase 3
Trial of sertraline to prevent post-traumatic brain injury depressioDepressive disorder after traumatic brain injuryMental and Behavioural Disorders
ISRCTN17518945King's College Hospital514
Completed
Not Applicable
Internet-based relapse prevention for in-patients with anorexia nervosaSevere anorexia nervosa (AN)Mental and Behavioural DisordersEating disorders
ISRCTN18274621South London and Maudsley NHS Foundation Trust (UK)98